
MOWOOT, the belt against chronic constipation
Sergi Bassolas interviews Markus Wilhelms at the radio show Amics i Coneguts, Ràdio 4 (CAT).
Sergi Bassolas interviews Markus Wilhelms at the radio show Amics i Coneguts, Ràdio 4 (CAT).
Our first Mowooter, Francisco Zuasti, was interviewed for the radio channel COPE. He explained MOWOOT has solved his constipation and the experience of another ASPAYM Cádiz members.
Immaculada Herrero Fresneda, responsible for studies and clinical evaluation of MOWOOT, was interviewed for El País during an EIT Health meeting in Paris.
The magazine Sobre Ruedas from the Institut Guttmann publishes a report on the usMIMA’s team and the development of MOWOOT in response to chronic constipation. SHOW MORE
Immaculada Herrero, CSO of usMIMA, has been invited to the program Tot és possible from the leading radio network in Catalonia RAC 1, to present MOWOOT, the portable device against chronic constipation.
The radio channel Radio 4 from RNE interviews Markus Wilhelms, CEO of usMIMA, in the Club 21 program. Wilhelms explains what MOWOOT is, the product that is born to solve chronic constipation. ONLY AVAILABLE IN LOCAL LANGUAGE. SHOW MORE
The science program Què Qui Com of Canal 33 emits an episode about constipation and good depositional habits in which Inmaculada Herrero, CSO of usMIMA, participates to introduce MOWOOT. ONLY AVAILABLE IN LOCAL LANGUAGE. SHOW MORE
The newspaper El Mundo publishes an interview with Markus Wilhelms, CEO of usMIMA, explaining the beginning and international launch of the MOWOOT device. DOWNLOAD
Punt Avui publishes an interview with Markus Wilhelms, microbiology doctor and CEO of usMIMA, a company that has devised and commercialized the first device to combat chronic constipation, a problem that makes life difficult for patients with stroke or spinal cord injury (in Catalan). ONLY AVAILABLE IN LOCAL LANGUAGE. SHOW MORE
The radio channel COPE broadcasts an interview with Markus Wilhelms, CEO of usMIMA, explaining how MOWOOT was created, its features and functioning to treat chronic constipation. ONLY AVAILABLE IN LOCAL LANGUAGE. SHOW MORE